|
Kring, A M; Alpert, M; Neale, J M et al. (1994) A multimethod, multichannel assessment of affective flattening in schizophrenia. Psychiatry Res 54:211-22
|
|
Serper, M R; Harvey, P D (1994) The need to integrate neuropsychological and experimental schizophrenia research. Schizophr Bull 20:1-11;discussion 13-21
|
|
Rosengarten, H; Schweitzer, J W; Friedhoff, A J (1994) Possible genetic factors underlying the pathophysiology of tardive dyskinesia. Pharmacol Biochem Behav 49:663-7
|
|
Spencer, E K; Alpert, M; Pouget, E R (1994) Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS. Psychopharmacol Bull 30:199-202
|
|
Rosengarten, H; Schweitzer, J W; Friedhoff, A J (1993) A mechanism underlying neuroleptic induced oral dyskinesias in rats. Pol J Pharmacol 45:391-8
|
|
Franssen, E H; Kluger, A; Torossian, C L et al. (1993) The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline. Arch Neurol 50:1029-39
|
|
Silva, R R; Friedhoff, A J; Alpert, M (1993) Neuroleptic withdrawal psychosis in Tourette's disorder. Biol Psychiatry 34:341-2
|
|
Thompson, M A; Lee, E; Lawe, D et al. (1992) Nerve growth factor-induced derepression of peripherin gene expression is associated with alterations in proteins binding to a negative regulatory element. Mol Cell Biol 12:2501-13
|
|
Wu, J; Filer, D; Friedhoff, A J et al. (1992) Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis. J Biol Chem 267:25754-8
|
|
Meller, E; Puza, T; Miller, J C et al. (1991) Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro. J Pharmacol Exp Ther 257:668-75
|
Showing the most recent 10 out of 59 publications
